PDF
ePub
Citation
Print
Abstract
Purpose
Transient tachypnea of the newborn (TTN) is a respiratory disorder resulting from delayed clearance of fetal lung fluid. Initiation of empiric antibiotic therapy for possible early-onset sepsis is usually recommended until negative blood cultures for 48 hours. The aim of this study was to compare outcomes of infants with TTN managed with a risk-factor-based restrictive antibiotic use policy.
Methods
A single institution retrospective study was conducted on full-term infants admitted with TTN from January, 2008 to December, 2013. Infants were stratified into two groups based on whether they received or did not receive antibiotics. The decision to administer antibiotics depended upon the covering physician at admission. The clinical and laboratory outcomes were evaluated between two groups.
Result
A total of 98 full-term infants diagnosed with TTN were admitted to the neonatal intensive care unit; of them 39 (39.8%) received and 59 (60.2%) did not receive antibiotics. Physicians had tendency to start antibiotics in patient with mild-to-moderate chest retraction, need oxygen therapy, high white blood cell count, segmented neutrophil and positive C-reactive protein. All of them had negative blood cultures, no readmission, and no late-onset sepsis. The duration of hospital stay was longer in patients received antibiotics group (10.7±3.0 days vs. 9.0±4.4 days, P=0.04).
References
1. Jalal M. Abu-Shaweesh JM. Respiratory disorders in preterm and term infants. In Martin RJ, Fanaroff AA, Walsh MC, editors, Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. 9th ed.St. Louis: Elsevier Mosby;2006. p. 1162–3.
2. Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol. 2005; 25:251–7.
3. Takaya A, Igarashi M, Nakajima M, Miyake H, Shima Y, Suzuki S. Risk factors for transient tachypnea of the newborn in infants delivered vaginally at 37 weeks or later. J Nippon Med Sch. 2008; 75:269–73.
4. Lewis V, Whitelaw A. Furosemide for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2002; 1:CD003064.
5. Downes JJ, Vidyasagar D, Boggs TR Jr, Morrow GM 3rd. Respiratory distress syndrome of newborn infants. I. New clinical scoring system (RDS score) with acid-base and blood-gas correlations. Clin Pediatr. 1970; 9:325–31.
6. Welty S, Hansen TN, Corbet A. Respiratory distress in the preterm infant. In Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed.Philadelphia: Elsevior Saunders;2006. p. 697–9.
7. Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006; 30:34–43.
8. French GL. Clinical impact and relevance of antibiotic resistance. Adv Drug Deliv Rev. 2005; 57:1514–27.
9. Weintraub AS, Cadet CT, Perez R, DeLorenzo E, Holzman IR, Stroustrup A. Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology. 2013; 103:235–40.
10. Costa S, Rocha G, Leitão A, Guimarães H. Transient tachypnea of the newborn and congenital pneumonia: A comparative study. J Matern Fetal Neonatal Med. 2012; 25.
11. Salama H, Abughalwa M, Taha S, Sharaf N, Mansour A. Transient tachypnea of the newborn: Is empiric antimicrobial therapy needed? J Neonatal Perinatal Med. 2013; 6:237–41.
12. Ma XL, Xu XF, Chen C, Yan CY, Liu YM, Liu L, et al. National Collaborative Study Group for neonatal Respiratory Distress in Late Preterm or Term Infants. Epidemiology of respiratory distress and the illness severity in late preterm or term infants: a prospective multicenter study. Chin Med J. 2010; 123:2776–80.
Table 1.
Clinical characteristics of study subjects
SATable 2.
Clinical symptoms at admission
XML Download